HealthStream Inc (HSTM)
HealthStream Announces Third Quarter 2025 Results
Nanobiotix S.A. (NBTX)
NANOBIOTIX to Participate in Investor Conferences the Week of November 10th
Myomo Inc (MYO)
Myomo to Report Third Quarter 2025 Financial Results on November 10
Eastman Chemical Company (EMN)
Eastman Announces Third-Quarter 2025 Financial Results
Zoetis Inc. (ZTS)
Zoetis Announces Retirement of Rob Polzer at the End of 2025 and the Appointment of Kevin Esch as President of Research & Development for World Leader in Animal Health Beginning in 2026
UFP Technologies Inc (UFPT)
UFP Technologies Announces Strong Q3 2025 Results
The Ensign Group Inc (ENSG)
The Ensign Group Reports Third Quarter 2025 Results; Raises Annual Earnings and Revenue Guidance
Castle Biosciences Inc (CSTL)
Castle Biosciences Reports Third Quarter 2025 Results
Myriad Genetics Inc (MYGN)
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
Abivax (ABVX)
Abivax Announces Patient-Reported Outcomes Data from the Phase 3 ABTECT Induction Trials of Obefazimod, Demonstrating Significant Improvements in Quality of Life for Patients with Moderate-to-Severely Active Ulcerative Colitis